Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date08 Jan 2004 |
/ Not yet recruitingPhase 4IIT The efficacy and safety of Dazhu Rhodiola injection in the treatment of coronary heart disease and angina pectoris: a randomized, open-label, multi-center real world clinical study
100 Clinical Results associated with Tonghua Yu Sheng Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Tonghua Yu Sheng Pharmaceutical Co. Ltd.
100 Deals associated with Tonghua Yu Sheng Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Tonghua Yu Sheng Pharmaceutical Co. Ltd.